http://www.dailypolitical.com/2017/01/18/murphy-capital-management-inc-cuts-stake-in-merck-company-inc-mrk.html
http://www.businesswire.com/news/home/20170118005366/en/Merck-Foundation-Grant-Expands-Project-ECHO%C2%AE-Vietnam/?feedref=JjAwJuNHiystnCoBq_hl-YorNIXXeJUidDamMzBr2lUAKMtEGtRj-e8KfM-o9q9qrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3miEx88JtThI8BEp2XznrHLRzAC4_rGwOLNoA4bcgbFNw==
http://www.pmlive.com/pharma_news/az_tweaks_immuno-oncology_trials_as_it_chases_lung_cancer_leaders_1184524
http://www.prnewswire.com/news-releases/technical-reports-on-drug-makers-stocks----pfizer-merck-abbvie-and-johnson--johnson-611050165.html
http://www.themalaymailonline.com/money/article/drugmakers-in-davos-shift-focus-to-chronic-diseases-of-poor
http://www.marketwatch.com/story/technical-reports-on-drug-makers-stocks----pfizer-merck-abbvie-and-johnson-johnson-2017-01-18
http://www.dailypolitical.com/2017/01/17/rand-wealth-llc-increases-stake-in-merck-company-inc-mrk.html
http://www.dailypolitical.com/2017/01/17/granite-investment-partners-llc-has-956000-position-in-merck-company-inc-mrk.html
http://www.prnewswire.com/news-releases/agenus-announces-collaboration-with-the-national-cancer-institute-to-evaluate-the-combination-of-pembrolizumab-keytruda-merck--co-inc-with-prophage-agenus-inc-autologous-vaccine-300391721.html
http://www.prnewswire.com/news-releases/merck-opens-production-facility-exclusively-for-meglumine-in-spain-300383530.html
http://www.perssupport.nl/persbericht/116870/merck-opens-production-facility-exclusively-for-meglumine-in-spain
http://www.prnewswire.co.uk/news-releases/410918385.html
http://www.pmlive.com/pharma_news/merck_forges_cancer-focused_big_data_alliance_with_palantir_1184371
http://www.dailypolitical.com/2017/01/16/train-babcock-advisors-llc-has-769000-stake-in-merck-company-inc-mrk.html
https://www.bloomberg.com/gadfly/articles/2017-01-18/astrazeneca-cancer-trial-changes-not-enough-to-catch-up
http://www.ssuchronicle.com/2017/01/18/connect-with-drugdev-at-the-scope-summit-for-clinical-operations-executives-for-engaging-customer-led-panel-discussions-and-the-anticipated-reveal-of-drugdev-spark/
http://www.timeslive.co.za/sundaytimes/businesstimes/2017/01/18/Drugmakers-in-Davos-shift-focus-to-chronic-diseases-of-poor
http://www.portstephensexaminer.com.au/story/3816758/collateral-damage-a-risk-from-bionomics-board-row/
http://www.heart.org/HEARTORG/Professional/GetWithTheGuidelines/GetWithTheGuidelines-Stroke/Get-With-The-Guidelines-Stroke-Overview_UCM_308021_Article.jsp
https://in.news.yahoo.com/drugmakers-davos-shift-focus-chronic-diseases-poor-052438072--finance.html
http://www.theglobeandmail.com/report-on-business/international-business/european-business/drug-makers-in-davos-shift-focus-to-chronic-diseases-of-poor/article33653610/
http://www.dailymail.co.uk/~/article-4131710/index.html
http://www.manufacturingchemist.com/news/article_page/Merck_opens_production_facility_exclusively_for_meglumine/124708
http://www.timesofmalta.com/articles/view/20170118/world/drugmakers-in-davos-shift-focus-to-chronic-diseases-of-poor.636875
http://ewn.co.za/2017/01/18/wef2017-drugmakers-in-davos-shift-focus-to-chronic-diseases-of-poor
http://www.thehindubusinessline.com/companies/panacea-inks-pact-with-unicef-gets-usfda-nod-for-migraine-drug/article9487387.ece
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panacea-inks-pact-with-unicefgets-usfda-nod-for-migraine-drug/articleshow/56643261.cms
/news/business/2017/0118/845782-drugmakers-in-davos-shift-focus-to-chronic-disease/
http://www.dailymail.co.uk/~/article-4130844/index.html
http://www.business-standard.com/article/reuters/drugmakers-in-davos-shift-focus-to-chronic-diseases-of-poor-117011800241_1.html
http://www.reuters.com/article/us-davos-meeting-pharmaceuticals-poor-idUSKBN1520GM
http://www.reuters.com/article/markets-swiss-stocks-idUSL5N1F749Y
http://gulfnews.com/business/sectors/features/australia-s-medical-sciences-expertise-gets-its-due-1.1963249
http://www.naturalnews.com/2017-01-17-american-college-of-pediatricians-hpv-vaccine-causes-ovarian-failure.html
http://www.sfgate.com/business/article/New-FDA-chief-should-have-medical-experience-10863445.php
https://www.bloomberg.com/news/articles/2017-01-17/new-fda-chief-should-have-medical-experience-drugmakers-say
http://www.emailwire.com/release/332220-Pediatric-Vaccines-Market-by-Material-Data-Validation-Analysis-and-Forecast-2022.html
http://www.prnewswire.com/news-releases/cross-border-cooperation-in-rd-on-the-rise-speeding-growth-of-sciencebusiness-network-610902075.html
http://www.prnewswire.co.uk/news-releases/cross-border-cooperation-in-rd-on-the-rise-speeding-growth-of-sciencebusiness-network-610902755.html
http://www.ssuchronicle.com/2017/01/16/global-monoclonal-antibody-therapeutics-market-spike-in-cancer-cases-around-the-world-to-ensure-swift-uptake-predicts-tmr/
http://www.marketwatch.com/story/immunotherapy-drugs-market-by-type-of-drugs-therapy-area-end-user-region---global-forecast-to-2021-2017-01-18
http://www.straitstimes.com/world/in-brief-firms-unite-to-plug-hydrogen-as-fuel
http://www.business-standard.com/article/markets/panacea-biotec-zooms-18-on-usfda-approval-for-migraine-drug-117011800417_1.html
http://www.marketwatch.com/story/global-chemotherapy-induced-nausea-and-vomiting-drugs-market-2017-2021-increasing-inorganic-growth-strategies-fuel-market-growth---research-and-markets-2017-01-18
http://www.prnewswire.com/news-releases/astellas-announces-participation-in-access-accelerated-300392575.html
http://www.prnewswire.com/news-releases/global-influenza-vaccines---world-industry-market-outlook-2017-2027-611063475.html
http://www.rundirectmagazine.com/global-anti-hypertensive-drugs-market-global-industry-analysis-industry-outlook-and-strategies-to-2023/45148/
http://www.rundirectmagazine.com/angiotensin-converting-enzyme-ace-inhibitors-market-growth-share-opportunities-competitive-analysis-and-forecast-2016-to-2023-credence-research/45146/
http://www.pr.com/press-release/701991
http://economictimes.indiatimes.com/markets/stocks/news/cadila-set-to-buy-us-firm-for-171-million/articleshow/56636993.cms
http://www.prnewswire.com/news-releases/institute-for-clinical-immuno-oncology-white-paper-highlights-the-challenges-progress-and-priorities-in-immunotherapy-300392169.html
http://www.prnewswire.co.uk/news-releases/biotech-showcase-2017-gathered-3000-investors-and-executives-from-the-life-sciences-industry-in-san-francisco-last-week-610963155.html
http://www.prnewswire.com/news-releases/200-billion-active-pharmaceutical-ingredientsapi-market-2016-2021-market-is-expected-to-reach-usd-21397-billion-by-2021-from-usd-15795-billion-in-2016---research-and-markets-300391878.html
http://www.prnewswire.co.uk/news-releases/200-billion-active-pharmaceutical-ingredientsapi-market-2016-2021-market-is-expected-to-reach-usd-21397-billion-by-2021-from-usd-15795-billion-in-2016---research-and-markets-610955845.html
http://medcitynews.com/2017/01/oncology-rare-diseases-little-genomic-diversity-3-themes-jpm17/
http://www.marketwatch.com/story/update-on-monoclonal-antibody-therapies-for-multiple-sclerosis-2017-01-17
http://www.prnewswire.com/news-releases/update-on-monoclonal-antibody-therapies-for-multiple-sclerosis-610917455.html
http://www.prnewswire.com/news-releases/enhancing-patient-outcomes--practical-approaches-to-treatment-optimisation-in-parkinsons-disease-610916125.html
http://www.prnewswire.co.uk/news-releases/update-on-monoclonal-antibody-therapies-for-multiple-sclerosis-610917435.html
http://www.prnewswire.co.uk/news-releases/enhancing-patient-outcomes--practical-approaches-to-treatment-optimisation-in-parkinsons-disease-610916045.html
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2017-0043&format=XML&language=EN
http://www.business-standard.com/article/pti-stories/panacea-biotec-zooms-nearly-18-on-usfda-nod-for-migraine-drug-117011800923_1.html
http://www.prnewswire.com/news-releases/22-biopharma-companies-partner-and-launch-first-of-its-kind-global-initiative-to-address-rise-of-non-communicable-diseases-300392195.html
http://www.marketwatch.com/story/22-biopharma-companies-partner-and-launch-first-of-its-kind-global-initiative-to-address-rise-of-non-communicable-diseases-2017-01-18
